{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:27:29Z","timestamp":1780396049860,"version":"3.54.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00117-020-00729-8","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T13:04:08Z","timestamp":1597064648000},"page":"781-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Abdominelle Manifestationen bei\u00a0Mukoviszidose","Abdominal manifestations in cystic fibrosis"],"prefix":"10.1007","volume":"60","author":[{"given":"Olaf","family":"Sommerburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Peter","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"729_CR1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc08-0466","volume":"31","author":"AI Adler","year":"2008","unstructured":"Adler\u00a0AI, Shine\u00a0BS, Chamnan\u00a0P et al (2008) Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a\u00a0British cohort of children and adults. Diabetes Care 31:1789\u20131794","journal-title":"Diabetes Care"},{"key":"729_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcf.2010.03.006","volume":"9","author":"A Andrieux","year":"2010","unstructured":"Andrieux\u00a0A, Harambat\u00a0J, Bui\u00a0S et\u00a0al (2010) Renal impairment in children with cystic fibrosis. J\u00a0Cyst Fibros 9:263\u2013268","journal-title":"J Cyst Fibros"},{"key":"729_CR3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MEG.0b013e3282f36d04","volume":"20","author":"A Augarten","year":"2008","unstructured":"Augarten\u00a0A, Ben Tov\u00a0A, Madgar\u00a0I et\u00a0al (2008) The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype. Eur J Gastroenterol Hepatol 20:164\u2013168","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"729_CR4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.2009.1295","volume":"302","author":"JR Bartlett","year":"2009","unstructured":"Bartlett\u00a0JR, Friedman\u00a0KJ, Ling\u00a0SC et\u00a0al (2009) Genetic modifiers of liver disease in cystic fibrosis. JAMA 302:1076\u20131083","journal-title":"JAMA"},{"key":"729_CR5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/thx.2006.067595","volume":"62","author":"C Bertenshaw","year":"2007","unstructured":"Bertenshaw\u00a0C, Watson\u00a0AR, Lewis\u00a0S et\u00a0al (2007) Survey of acute renal failure in patients with cystic fibrosis in the UK. Thorax 62:541\u2013545","journal-title":"Thorax"},{"key":"729_CR6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2017-210394","volume":"73","author":"L Bessonova","year":"2018","unstructured":"Bessonova\u00a0L, Volkova\u00a0N, Higgins\u00a0M et\u00a0al (2018) Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor. Thorax 73:731\u2013740","journal-title":"Thorax"},{"key":"729_CR7","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2337\/db13-0510","volume":"62","author":"SM Blackman","year":"2013","unstructured":"Blackman\u00a0SM, Commander\u00a0CW, Watson\u00a0C et al (2013) Genetic modifiers of cystic fibrosis-related diabetes. Diabetes 62:3627\u20133635","journal-title":"Diabetes"},{"key":"729_CR8","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2006.07.016","volume":"131","author":"SM Blackman","year":"2006","unstructured":"Blackman\u00a0SM, Deering-Brose\u00a0R, Mcwilliams\u00a0R et al (2006) Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology 131:1030\u20131039","journal-title":"Gastroenterology"},{"key":"729_CR9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gut.2007.146134","volume":"57","author":"K Blondeau","year":"2008","unstructured":"Blondeau\u00a0K, Dupont\u00a0LJ, Mertens\u00a0V et al (2008) Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut 57:1049\u20131055","journal-title":"Gut"},{"key":"729_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MPG.0b013e3181acae98","volume":"50","author":"K Blondeau","year":"2010","unstructured":"Blondeau\u00a0K, Pauwels\u00a0A, Dupont\u00a0L et\u00a0al (2010) Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis. J\u00a0Pediatr Gastroenterol Nutr 50:161\u2013166","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"729_CR11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MCP.0b013e3283659ef2","volume":"19","author":"D Borowitz","year":"2013","unstructured":"Borowitz\u00a0D, Gelfond\u00a0D (2013) Intestinal complications of cystic fibrosis. Curr Opin Pulm Med 19:676\u2013680","journal-title":"Curr Opin Pulm Med"},{"key":"729_CR12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcf.2013.05.011","volume":"12","author":"D Borowitz","year":"2013","unstructured":"Borowitz\u00a0D, Gelfond\u00a0D, Maguiness\u00a0K et\u00a0al (2013) Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a\u00a0reconsideration. J\u00a0Cyst Fibros 12:784\u2013785","journal-title":"J Cyst Fibros"},{"key":"729_CR13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jpedsurg.2012.02.019","volume":"47","author":"BE Carlyle","year":"2012","unstructured":"Carlyle\u00a0BE, Borowitz\u00a0DS, Glick\u00a0PL (2012) A review of pathophysiology and management of fetuses and neonates with meconium ileus for the pediatric surgeon. J\u00a0Pediatr Surg 47:772\u2013781","journal-title":"J Pediatr Surg"},{"key":"729_CR14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MPG.0000000000001788","volume":"66","author":"A Carrion","year":"2018","unstructured":"Carrion\u00a0A, Borowitz\u00a0DS, Freedman\u00a0SD et\u00a0al (2018) Reduction of recurrence risk of pancreatitis in cystic fibrosis with Ivacaftor: case series. J\u00a0Pediatr Gastroenterol Nutr 66:451\u2013454","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"729_CR15","first-page":"CD000222","volume":"9","author":"K Cheng","year":"2017","unstructured":"Cheng\u00a0K, Ashby\u00a0D, Smyth\u00a0RL (2017) Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database Syst Rev 9:CD222","journal-title":"Cochrane Database Syst Rev"},{"key":"729_CR16","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2004.10.002","volume":"41","author":"C Colombo","year":"2004","unstructured":"Colombo\u00a0C, Battezzati\u00a0PM (2004) Liver involvement in cystic fibrosis: primary organ damage or innocent bystander? J\u00a0Hepatol 41:1041\u20131044","journal-title":"J Hepatol"},{"issue":"Suppl 2","key":"729_CR17","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1569-1993(11)60005-2","volume":"10","author":"C Colombo","year":"2011","unstructured":"Colombo\u00a0C, Ellemunter\u00a0H, Houwen\u00a0R et\u00a0al (2011) Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients. J\u00a0Cyst Fibros 10(Suppl 2):S24\u2013S28","journal-title":"J Cyst Fibros"},{"key":"729_CR18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2004.05.051","volume":"145","author":"K Corbett","year":"2004","unstructured":"Corbett\u00a0K, Kelleher\u00a0S, Rowland\u00a0M et al (2004) Cystic fibrosis-associated liver disease: a\u00a0population-based study. J\u00a0Pediatr 145:327\u2013332","journal-title":"J Pediatr"},{"key":"729_CR19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","volume":"41","author":"M Corey","year":"1988","unstructured":"Corey\u00a0M, Mclaughlin\u00a0FJ, Williams\u00a0M et\u00a0al (1988) A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J\u00a0Clin Epidemiol 41:583\u2013591","journal-title":"J Clin Epidemiol"},{"key":"729_CR20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1464-410x.2001.02242.x","volume":"88","author":"M Cornacchia","year":"2001","unstructured":"Cornacchia\u00a0M, Zenorini\u00a0A, Perobelli\u00a0S et\u00a0al (2001) Prevalence of urinary incontinence in women with cystic fibrosis. BJU Int 88:44\u201348","journal-title":"BJU Int"},{"key":"729_CR21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0022-3468(90)90186-D","volume":"25","author":"JP Coughlin","year":"1990","unstructured":"Coughlin\u00a0JP, Gauderer\u00a0MW, Stern\u00a0RC et\u00a0al (1990) The spectrum of appendiceal disease in cystic fibrosis. J\u00a0Pediatr Surg 25:835\u2013839","journal-title":"J Pediatr Surg"},{"key":"729_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(15)00545-7","volume":"4","author":"JC Davies","year":"2016","unstructured":"Davies\u00a0JC, Cunningham\u00a0S, Harris\u00a0WT et al (2016) Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2\u20135 years with cystic fibrosis and a\u00a0CFTR gating mutation (KIWI): an open-label, single-arm study. Lancet Respir Med 4:107\u2013115","journal-title":"Lancet Respir Med"},{"issue":"Suppl 2","key":"729_CR23","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","volume":"10","author":"D Debray","year":"2011","unstructured":"Debray\u00a0D, Kelly\u00a0D, Houwen\u00a0R et al (2011) Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J\u00a0Cyst Fibros 10(Suppl 2):S29\u2013S36","journal-title":"J Cyst Fibros"},{"key":"729_CR24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00431-016-2719-5","volume":"175","author":"S Demeyer","year":"2016","unstructured":"Demeyer\u00a0S, De Boeck\u00a0K, Witters\u00a0P et\u00a0al (2016) Beyond pancreatic insufficiency and liver disease in cystic fibrosis. Eur J Pediatr 175:881\u2013894","journal-title":"Eur J Pediatr"},{"key":"729_CR25","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.gastro.2003.08.016","volume":"125","author":"X Dray","year":"2003","unstructured":"Dray\u00a0X, Marteau\u00a0P, Bienvenu\u00a0T et\u00a0al (2003) Discussion on genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 125:1286","journal-title":"Gastroenterology"},{"key":"729_CR26","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/ajrccm.153.2.8564145","volume":"153","author":"DH Dreyfus","year":"1996","unstructured":"Dreyfus\u00a0DH, Bethel\u00a0R, Gelfand\u00a0EW (1996) Cystic fibrosis 3849+10\u202fkb C > T mutation associated with severe pulmonary disease and male fertility. Am J Respir Crit Care Med 153:858\u2013860","journal-title":"Am J Respir Crit Care Med"},{"key":"729_CR27","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1053\/gast.2002.37042","volume":"123","author":"C Durno","year":"2002","unstructured":"Durno\u00a0C, Corey\u00a0M, Zielenski\u00a0J et\u00a0al (2002) Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 123:1857\u20131864","journal-title":"Gastroenterology"},{"key":"729_CR28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/MPG.0b013e3181a3bfdd","volume":"50","author":"O Efrati","year":"2010","unstructured":"Efrati\u00a0O, Nir\u00a0J, Fraser\u00a0D et\u00a0al (2010) Meconium ileus in patients with cystic fibrosis is not a\u00a0risk factor for clinical deterioration and survival: the Israeli Multicenter Study. J\u00a0Pediatr Gastroenterol Nutr 50:173\u2013178","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"729_CR29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4254\/wjh.v9.i8.409","volume":"9","author":"G Engelmann","year":"2017","unstructured":"Engelmann\u00a0G, Quader\u00a0J, Teufel\u00a0U et al (2017) Limitations and opportunities of non-invasive liver stiffness measurement in children. World J Hepatol 9:409\u2013417","journal-title":"World J Hepatol"},{"key":"729_CR30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcf.2006.05.013","volume":"6","author":"C Etherington","year":"2007","unstructured":"Etherington\u00a0C, Bosomworth\u00a0M, Clifton\u00a0I et al (2007) Measurement of urinary N\u2011acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics. J\u00a0Cyst Fibros 6:67\u201373","journal-title":"J Cyst Fibros"},{"key":"729_CR31","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM199705013361803","volume":"336","author":"SC Fitzsimmons","year":"1997","unstructured":"Fitzsimmons\u00a0SC, Burkhart\u00a0GA, Borowitz\u00a0D et al (1997) High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N\u00a0Engl J Med 336:1283\u20131289","journal-title":"N Engl J Med"},{"key":"729_CR32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2012.11.010","volume":"12","author":"T Flass","year":"2013","unstructured":"Flass\u00a0T, Narkewicz\u00a0MR (2013) Cirrhosis and other liver disease in cystic fibrosis. J\u00a0Cyst Fibros 12:116\u2013124","journal-title":"J. Cyst. Fibros."},{"key":"729_CR33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1542-4758.2012.00675.x","volume":"16","author":"MC Florescu","year":"2012","unstructured":"Florescu\u00a0MC, Lyden\u00a0E, Murphy\u00a0PJ et al (2012) Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis. Hemodial Int 16:414\u2013419","journal-title":"Hemodial Int"},{"key":"729_CR34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","volume":"168","author":"RL Gibson","year":"2003","unstructured":"Gibson\u00a0RL, Burns\u00a0JL, Ramsey\u00a0BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918\u2013951","journal-title":"Am J Respir Crit Care Med"},{"key":"729_CR35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.123.1.37","volume":"123","author":"M Gilljam","year":"2003","unstructured":"Gilljam\u00a0M, Chaparro\u00a0C, Tullis\u00a0E et\u00a0al (2003) GI complications after lung transplantation in patients with cystic fibrosis. Chest 123:37\u201341","journal-title":"Chest"},{"issue":"8","key":"729_CR36","doi-asserted-by":"publisher","first-page":"e98240","DOI":"10.1172\/jci.insight.98240","volume":"3","author":"NJ Hart","year":"2018","unstructured":"Hart\u00a0NJ, Aramandla\u00a0R, Poffenberger\u00a0G et\u00a0al (2018) Cystic fibrosis-related diabetes is caused by islet loss and inflammation. JCI Insight 3(8):e98240. https:\/\/doi.org\/10.1172\/jci.insight.98240","journal-title":"JCI Insight"},{"key":"729_CR37","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MPG.0000000000000765","volume":"60","author":"D Hayes Jr.","year":"2015","unstructured":"Hayes\u00a0D Jr., Warren\u00a0PS, Mccoy\u00a0KS et\u00a0al (2015) Improvement of hepatic steatosis in cystic fibrosis with ivacaftor therapy. J\u00a0Pediatr Gastroenterol Nutr 60:578\u2013579","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"729_CR38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1542\/peds.48.1.51","volume":"48","author":"DS Holsclaw","year":"1971","unstructured":"Holsclaw\u00a0DS, Rocmans\u00a0C, Shwachman\u00a0H (1971) Intussusception in patients with cystic fibrosis. Pediatrics 48:51\u201358","journal-title":"Pediatrics"},{"key":"729_CR39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MPG.0b013e3181a6e01d","volume":"50","author":"RH Houwen","year":"2010","unstructured":"Houwen\u00a0RH, Van Der Doef\u00a0HP, Sermet\u00a0I et\u00a0al (2010) Defining DIOS and constipation in cystic fibrosis with a\u00a0multicentre study on the incidence, characteristics, and treatment of DIOS. J\u00a0Pediatr Gastroenterol Nutr 50:38\u201342","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"729_CR40","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/humrep\/dei453","volume":"21","author":"D Hubert","year":"2006","unstructured":"Hubert\u00a0D, Patrat\u00a0C, Guibert\u00a0J et\u00a0al (2006) Results of assisted reproductive technique in men with cystic fibrosis. Hum Reprod 21:1232\u20131236","journal-title":"Hum Reprod"},{"key":"729_CR41","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00044009","volume":"34","author":"JH Hull","year":"2009","unstructured":"Hull\u00a0JH, Garrod\u00a0R, Ho\u00a0TB et\u00a0al (2009) Increased augmentation index in patients with cystic fibrosis. Eur Respir\u00a0J 34:1322\u20131328","journal-title":"Eur Respir J"},{"key":"729_CR42","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00424-008-0594-2","volume":"457","author":"F Jouret","year":"2009","unstructured":"Jouret\u00a0F, Devuyst\u00a0O (2009) CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis. Pflugers Arch 457:1227\u20131236","journal-title":"Pflugers Arch"},{"key":"729_CR43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2013.02.008","volume":"12","author":"A Kelly","year":"2013","unstructured":"Kelly\u00a0A, Moran\u00a0A (2013) Update on cystic fibrosis-related diabetes. J\u00a0Cyst Fibros 12:318\u2013331","journal-title":"J Cyst Fibros"},{"key":"729_CR44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0022-3476(89)80134-9","volume":"114","author":"E Kerem","year":"1989","unstructured":"Kerem\u00a0E, Corey\u00a0M, Kerem\u00a0B et\u00a0al (1989) Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J\u00a0Pediatr 114:767\u2013773","journal-title":"J Pediatr"},{"key":"729_CR45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ppul.1142","volume":"32","author":"C Koch","year":"2001","unstructured":"Koch\u00a0C, Rainisio\u00a0M, Madessani\u00a0U et al (2001) Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 32:343\u2013350","journal-title":"Pediatr Pulmonol"},{"key":"729_CR46","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1067\/mpd.2003.152","volume":"142","author":"MW Konstan","year":"2003","unstructured":"Konstan\u00a0MW, Butler\u00a0SM, Wohl\u00a0ME et\u00a0al (2003) Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J\u00a0Pediatr 142:624\u2013630","journal-title":"J Pediatr"},{"key":"729_CR47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/j.1552-4604.1994.tb03981.x","volume":"34","author":"M Kraisinger","year":"1994","unstructured":"Kraisinger\u00a0M, Hochhaus\u00a0G, Stecenko\u00a0A et\u00a0al (1994) Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations. J\u00a0Clin Pharmacol 34:158\u2013166","journal-title":"J Clin Pharmacol"},{"key":"729_CR48","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2337\/dc10-2231","volume":"34","author":"M Lind-Ayres","year":"2011","unstructured":"Lind-Ayres\u00a0M, Thomas\u00a0W, Holme\u00a0B et al (2011) Microalbuminuria in patients with cystic fibrosis. Diabetes Care 34:1526\u20131528","journal-title":"Diabetes Care"},{"key":"729_CR49","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.1840160215","volume":"16","author":"A Lindblad","year":"1992","unstructured":"Lindblad\u00a0A, Hultcrantz\u00a0R, Strandvik\u00a0B (1992) Bile-duct destruction and collagen deposition: a\u00a0prominent ultrastructural feature of the liver in cystic fibrosis. Hepatology 16:372\u2013381","journal-title":"Hepatology"},{"key":"729_CR50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jnci\/95.5.381","volume":"95","author":"P Maisonneuve","year":"2003","unstructured":"Maisonneuve\u00a0P, Fitzsimmons\u00a0SC, Neglia\u00a0JP et al (2003) Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a\u00a010-year study. J\u00a0Natl Cancer Inst 95:381\u2013387","journal-title":"J Natl Cancer Inst"},{"key":"729_CR51","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","volume":"105","author":"P Maisonneuve","year":"2013","unstructured":"Maisonneuve\u00a0P, Marshall\u00a0BC, Knapp\u00a0EA et al (2013) Cancer risk in cystic fibrosis: a\u00a020-year nationwide study from the United States. J\u00a0Natl Cancer Inst 105:122\u2013129","journal-title":"J Natl Cancer Inst"},{"key":"729_CR52","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jcf.2011.04.004","volume":"10","author":"AC Malbrunot-Wagner","year":"2011","unstructured":"Malbrunot-Wagner\u00a0AC, Bridoux\u00a0L, Nousbaum\u00a0JB et al (2011) Transient elastography and portal hypertension in pediatric patients with cystic fibrosis Transient elastography and cystic fibrosis. J\u00a0Cyst Fibros 10:338\u2013342","journal-title":"J Cyst Fibros"},{"key":"729_CR53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","volume":"146","author":"BC Marshall","year":"2005","unstructured":"Marshall\u00a0BC, Butler\u00a0SM, Stoddard\u00a0M et al (2005) Epidemiology of cystic fibrosis-related diabetes. J\u00a0Pediatr 146:681\u2013687","journal-title":"J Pediatr"},{"key":"729_CR54","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1378\/chest.118.4.1059","volume":"118","author":"TJ Mccallum","year":"2000","unstructured":"Mccallum\u00a0TJ, Milunsky\u00a0JM, Cunningham\u00a0DL et\u00a0al (2000) Fertility in men with cystic fibrosis: an update on current surgical practices and outcomes. Chest 118:1059\u20131062","journal-title":"Chest"},{"key":"729_CR55","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0016-5085(84)80029-3","volume":"86","author":"VP Mccarthy","year":"1984","unstructured":"Mccarthy\u00a0VP, Mischler\u00a0EH, Hubbard\u00a0VS et\u00a0al (1984) Appendiceal abscess in cystic fibrosis. A diagnostic challenge. Gastroenterology 86:564\u2013568","journal-title":"Gastroenterology"},{"key":"729_CR56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2213-2600(18)30460-0","volume":"7","author":"JJ Mcnamara","year":"2019","unstructured":"Mcnamara\u00a0JJ, Mccolley\u00a0SA, Marigowda\u00a0G et al (2019) Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2\u20135 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study. Lancet Respir Med 7:325\u2013335","journal-title":"Lancet Respir Med"},{"key":"729_CR57","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2214\/ajr.184.6.01841901","volume":"184","author":"R Menten","year":"2005","unstructured":"Menten\u00a0R, Lebecque\u00a0P, Saint-Martin\u00a0C et al (2005) Outer diameter of the vermiform appendix: not a\u00a0valid sonographic criterion for acute appendicitis in patients with cystic fibrosis. AJR Am J Roentgenol 184:1901\u20131903","journal-title":"AJR Am J Roentgenol"},{"key":"729_CR58","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jcf.2011.05.003","volume":"10","author":"KC Meyer","year":"2011","unstructured":"Meyer\u00a0KC, Francois\u00a0ML, Thomas\u00a0HK et\u00a0al (2011) Colon cancer in lung transplant recipients with CF: increased risk and results of screening. J\u00a0Cyst Fibros 10:366\u2013369","journal-title":"J Cyst Fibros"},{"key":"729_CR59","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/lt.23389","volume":"18","author":"MR Miller","year":"2012","unstructured":"Miller\u00a0MR, Sokol\u00a0RJ, Narkewicz\u00a0MR et\u00a0al (2012) Pulmonary function in individuals who underwent liver transplantation: from the US cystic fibrosis foundation registry. Liver Transpl 18:585\u2013593","journal-title":"Liver Transpl"},{"key":"729_CR60","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1464-5491.2009.02738.x","volume":"26","author":"K Mohan","year":"2009","unstructured":"Mohan\u00a0K, Miller\u00a0H, Dyce\u00a0P et\u00a0al (2009) Mechanisms of glucose intolerance in cystic fibrosis. Diabet Med 26:582\u2013588","journal-title":"Diabet Med"},{"key":"729_CR61","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1590\/S0001-37652000000300013","volume":"72","author":"MM Morales","year":"2000","unstructured":"Morales\u00a0MM, Falkenstein\u00a0D, Lopes\u00a0AG (2000) The cystic fibrosis transmembrane regulator (CFTR) in the kidney. An Acad Bras Cienc 72:399\u2013406","journal-title":"An Acad Bras Cienc"},{"issue":"Suppl 27","key":"729_CR62","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/pedi.12732","volume":"19","author":"A Moran","year":"2018","unstructured":"Moran\u00a0A, Pillay\u00a0K, Becker\u00a0D et al (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes 19(Suppl 27):64\u201374","journal-title":"Pediatr Diabetes"},{"key":"729_CR63","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1742-1241.2003.tb10460.x","volume":"57","author":"F Moran","year":"2003","unstructured":"Moran\u00a0F, Bradley\u00a0JM, Boyle\u00a0L et\u00a0al (2003) Incontinence in adult females with cystic fibrosis: a\u00a0Northern Ireland survey. Int J Clin Pract 57:182\u2013183","journal-title":"Int J Clin Pract"},{"key":"729_CR64","unstructured":"Naehrlich\u00a0L, Burkhart\u00a0M, Wosniok\u00a0J (2019) Deutsches Mukoviszidose-Register \u2013 Berichtsband 2018. https:\/\/www.muko.info\/fileadmin\/user_upload\/angebote\/qualitaetsmanagement\/register\/berichtsbaende\/berichtsband_2018.pdf. Zugegriffen: 30.07.2020"},{"key":"729_CR65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1399-0012.2010.01395.x","volume":"26","author":"EF Nash","year":"2012","unstructured":"Nash\u00a0EF, Volling\u00a0C, Gutierrez\u00a0CA et al (2012) Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis. Clin Transplant 26:34\u201341","journal-title":"Clin Transplant"},{"key":"729_CR66","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199502233320803","volume":"332","author":"JP Neglia","year":"1995","unstructured":"Neglia\u00a0JP, Fitzsimmons\u00a0SC, Maisonneuve\u00a0P et\u00a0al (1995) The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N\u00a0Engl J Med 332:494\u2013499","journal-title":"N Engl J Med"},{"key":"729_CR67","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1542\/peds.110.2.e22","volume":"110","author":"GM Nixon","year":"2002","unstructured":"Nixon\u00a0GM, Glazner\u00a0JA, Martin\u00a0JM et\u00a0al (2002) Urinary incontinence in female adolescents with cystic fibrosis. Pediatrics 110:e22","journal-title":"Pediatrics"},{"key":"729_CR68","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1378\/chest.12-2057","volume":"143","author":"OJ O\u2019connell","year":"2013","unstructured":"O\u2019connell\u00a0OJ, Harrison\u00a0MJ, Murphy\u00a0DM et al (2013) Peri-lung transplant renal issues in patients with cystic fibrosis. Chest 143:271","journal-title":"Chest"},{"key":"729_CR69","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1378\/chest.11-1573","volume":"141","author":"A Pauwels","year":"2012","unstructured":"Pauwels\u00a0A, Decraene\u00a0A, Blondeau\u00a0K et\u00a0al (2012) Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis. Chest 141:1568\u20131574","journal-title":"Chest"},{"key":"729_CR70","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0022-5347(01)69068-2","volume":"167","author":"MR Perez-Brayfield","year":"2002","unstructured":"Perez-Brayfield\u00a0MR, Caplan\u00a0D, Gatti\u00a0JM et al (2002) Metabolic risk factors for stone formation in patients with cystic fibrosis. J\u00a0Urol 167:480\u2013484","journal-title":"J Urol"},{"key":"729_CR71","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201105-0932OC","volume":"184","author":"BS Quon","year":"2011","unstructured":"Quon\u00a0BS, Mayer-Hamblett\u00a0N, Aitken\u00a0ML et al (2011) Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Care Med 184:1147\u20131152","journal-title":"Am J Respir Crit Care Med"},{"key":"729_CR72","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1053\/rmed.2000.0874","volume":"94","author":"HC Rodgers","year":"2000","unstructured":"Rodgers\u00a0HC, Baldwin\u00a0DR, Knox\u00a0AJ (2000) Questionnaire survey of male infertility in cystic fibrosis. Respir Med 94:1002\u20131003","journal-title":"Respir Med"},{"key":"729_CR73","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2213-2600(18)30202-9","volume":"6","author":"M Rosenfeld","year":"2018","unstructured":"Rosenfeld\u00a0M, Wainwright\u00a0CE, Higgins\u00a0M et al (2018) Ivacaftor treatment of cystic fibrosis in children aged 12 to \u300824\u00a0months and with a\u00a0CFTR gating mutation (ARRIVAL): a\u00a0phase 3 single-arm study. Lancet Respir Med 6:545\u2013553","journal-title":"Lancet Respir Med"},{"key":"729_CR74","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","volume":"190","author":"SM Rowe","year":"2014","unstructured":"Rowe\u00a0SM, Heltshe\u00a0SL, Gonska\u00a0T et al (2014) Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis. Am J Respir Crit Care Med 190:175\u2013184","journal-title":"Am J Respir Crit Care Med"},{"key":"729_CR75","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ajg.2010.316","volume":"106","author":"M Rowland","year":"2011","unstructured":"Rowland\u00a0M, Gallagher\u00a0CG, O\u2019laoide\u00a0R et\u00a0al (2011) Outcome in cystic fibrosis liver disease. Am J Gastroenterol 106:104\u2013109","journal-title":"Am J Gastroenterol"},{"key":"729_CR76","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1542\/peds.78.3.473","volume":"78","author":"S Rubinstein","year":"1986","unstructured":"Rubinstein\u00a0S, Moss\u00a0R, Lewiston\u00a0N (1986) Constipation and meconium ileus equivalent in patients with cystic fibrosis. Pediatrics 78:473\u2013479","journal-title":"Pediatrics"},{"key":"729_CR77","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jcf.2010.06.004","volume":"9","author":"AA Sabati","year":"2010","unstructured":"Sabati\u00a0AA, Kempainen\u00a0RR, Milla\u00a0CE et\u00a0al (2010) Characteristics of gastroesophageal reflux in adults with cystic fibrosis. J\u00a0Cyst Fibros 9:365\u2013370","journal-title":"J Cyst Fibros"},{"key":"729_CR78","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/thx.2004.027599","volume":"60","author":"SM Sawyer","year":"2005","unstructured":"Sawyer\u00a0SM, Farrant\u00a0B, Cerritelli\u00a0B et\u00a0al (2005) A survey of sexual and reproductive health in men with cystic fibrosis: new challenges for adolescent and adult services. Thorax 60:326\u2013330","journal-title":"Thorax"},{"key":"729_CR79","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1099-0496(199804)25:4<226::AID-PPUL2>3.0.CO;2-I","volume":"25","author":"SM Sawyer","year":"1998","unstructured":"Sawyer\u00a0SM, Tully\u00a0MA, Dovey\u00a0ME et\u00a0al (1998) Reproductive health in males with cystic fibrosis: knowledge, attitudes, and experiences of patients and parents. Pediatr Pulmonol 25:226\u2013230","journal-title":"Pediatr Pulmonol"},{"key":"729_CR80","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2337\/dc06-1576","volume":"30","author":"SJ Schwarzenberg","year":"2007","unstructured":"Schwarzenberg\u00a0SJ, Thomas\u00a0W, Olsen\u00a0TW et al (2007) Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 30:1056\u20131061","journal-title":"Diabetes Care"},{"key":"729_CR81","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(98)03038-4","volume":"352","author":"H Sidhu","year":"1998","unstructured":"Sidhu\u00a0H, Hoppe\u00a0B, Hesse\u00a0A et\u00a0al (1998) Absence of Oxalobacter formigenes in cystic fibrosis patients: a\u00a0risk factor for hyperoxaluria. Lancet 352:1026\u20131029","journal-title":"Lancet"},{"key":"729_CR82","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/thx.2007.088757","volume":"63","author":"A Smyth","year":"2008","unstructured":"Smyth\u00a0A, Lewis\u00a0S, Bertenshaw\u00a0C et al (2008) Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Thorax 63:532\u2013535","journal-title":"Thorax"},{"key":"729_CR83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(94)90817-6","volume":"343","author":"RL Smyth","year":"1994","unstructured":"Smyth\u00a0RL, Van Velzen\u00a0D, Smyth\u00a0AR et al (1994) Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 343:85\u201386","journal-title":"Lancet"},{"key":"729_CR84","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/thorax.57.7.596","volume":"57","author":"G Steinkamp","year":"2002","unstructured":"Steinkamp\u00a0G, Wiedemann\u00a0B (2002) Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 57:596\u2013601","journal-title":"Thorax"},{"key":"729_CR85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcf.2017.11.016","volume":"17","author":"JC Thomassen","year":"2018","unstructured":"Thomassen\u00a0JC, Mueller\u00a0MI, Alejandre Alcazar\u00a0MA et\u00a0al (2018) Effect of Lumacaftor\/Ivacaftor on glucose metabolism and insulin secretion in Phe508del homozygous cystic fibrosis patients. J\u00a0Cyst Fibros 17:271\u2013275","journal-title":"J Cyst Fibros"},{"key":"729_CR86","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","volume":"35","author":"D Turck","year":"2016","unstructured":"Turck\u00a0D, Braegger\u00a0CP, Colombo\u00a0C et al (2016) ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr 35:557\u2013577","journal-title":"Clin Nutr"},{"key":"729_CR87","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11894-011-0185-9","volume":"13","author":"HP Van Der Doef","year":"2011","unstructured":"Van Der Doef\u00a0HP, Kokke\u00a0FT, Van Der Ent\u00a0CK et\u00a0al (2011) Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation. Curr Gastroenterol Rep 13:265\u2013270","journal-title":"Curr Gastroenterol Rep"},{"key":"729_CR88","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/nau.20732","volume":"28","author":"M Vella","year":"2009","unstructured":"Vella\u00a0M, Cartwright\u00a0R, Cardozo\u00a0L et al (2009) Prevalence of incontinence and incontinence-specific quality of life impairment in women with cystic fibrosis. Neurourol Urodyn 28:986\u2013989","journal-title":"Neurourol Urodyn"},{"key":"729_CR89","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MEG.0b013e3282f36d16","volume":"20","author":"J Walkowiak","year":"2008","unstructured":"Walkowiak\u00a0J, Lisowska\u00a0A, Blaszczynski\u00a0M (2008) The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype. Eur J Gastroenterol Hepatol 20:157\u2013160","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"729_CR90","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jcf.2013.05.003","volume":"12","author":"H White","year":"2013","unstructured":"White\u00a0H, Morton\u00a0AM, Conway\u00a0SP et\u00a0al (2013) Enteral tube feeding in adults with cystic fibrosis; patient choice and impact on long term outcomes. J\u00a0Cyst Fibros 12:616\u2013622","journal-title":"J Cyst Fibros"},{"key":"729_CR91","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00005176-199902000-00017","volume":"28","author":"M Wilschanski","year":"1999","unstructured":"Wilschanski\u00a0M, Fisher\u00a0D, Hadas-Halperin\u00a0I et al (1999) Findings on routine abdominal ultrasonography in cystic fibrosis patients. J\u00a0Pediatr Gastroenterol Nutr 28:182\u2013185","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"729_CR92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.4.1.53","volume":"4","author":"WW Zuelzer","year":"1949","unstructured":"Zuelzer\u00a0WW, Newton\u00a0WA Jr. (1949) The pathogenesis of fibrocystic disease of the pancreas; a\u00a0study of 36 cases with special reference to the pulmonary lesions. Pediatrics 4:53\u201369","journal-title":"Pediatrics"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-020-00729-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-020-00729-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-020-00729-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T14:38:31Z","timestamp":1696516711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-020-00729-8"}},"subtitle":["Klinische \u00dcbersicht","Clinical review"],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":92,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1007\/s00117-020-00729-8","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]},"assertion":[{"value":"10 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"O.\u00a0Sommerburg und J.-P.\u00a0Schenk geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}